TH1 cytokines induce senescence in AML. (June 2022)
- Record Type:
- Journal Article
- Title:
- TH1 cytokines induce senescence in AML. (June 2022)
- Main Title:
- TH1 cytokines induce senescence in AML
- Authors:
- Hashimoto, Hisayoshi
Güngör, Derya
Krickeberg, Naomi
Schmitt, Johanna
Doll, Larissa
Schmidt, Marina
Schleicher, Sabine
Criado-Moronati, Elvira
Schilbach, Karin - Abstract:
- Abstract: Cancer testis antigen PRAME is over-expressed in a variety of malignant cells but is not or minimally expressed in normal non-germ line cells. Adoptive transfer of PRAME-specific T cells is thus under investigation in clinical trials as an innovative therapeutic option for acute myeloid leukemia (AML). However, their senescence-inducing activity has not been studied. This study therefore examines senescence induction in AML cells by PRAME-specific TH 1 cells. Analysis of cell cycle and marker expression demonstrate that the supernatants of antigen-stimulated PRAME-specific TH 1 cells induce senescence in AML cell lines Kasumi and Nomo-1 through combinative IFN-γ and TNF-α. Additionally IFN-γ and TNF-α secreted by TCR-activated Vδ2 + or CMV-specific T cells can also drive these AML cell lines into terminal growth arrest. G1/0 arrest is also suggested in patient-derived AML by TH 1 cytokines or supernatants from Zoledronate-stimulated or aCD3/aCD28-stimulated PBMCs. Thus, we show for the first time that senescence is induced in AML cells by combined IFN-γ and TNF-α, and that these cytokines can be derived either from TCR-engineered CD4 + T cells, or intriguingly from Virus-specific as well as innate Vδ2 + T cells responding to their cognate antigens, namely T-cell responses targeting an antigen that is NOT expressed by the leukemic cells. Graphical Abstract: ga1 Highlights: TH 1 cytokines IFN-γ and TNF-α combined induce senescence in acute myeloid leukemia.Abstract: Cancer testis antigen PRAME is over-expressed in a variety of malignant cells but is not or minimally expressed in normal non-germ line cells. Adoptive transfer of PRAME-specific T cells is thus under investigation in clinical trials as an innovative therapeutic option for acute myeloid leukemia (AML). However, their senescence-inducing activity has not been studied. This study therefore examines senescence induction in AML cells by PRAME-specific TH 1 cells. Analysis of cell cycle and marker expression demonstrate that the supernatants of antigen-stimulated PRAME-specific TH 1 cells induce senescence in AML cell lines Kasumi and Nomo-1 through combinative IFN-γ and TNF-α. Additionally IFN-γ and TNF-α secreted by TCR-activated Vδ2 + or CMV-specific T cells can also drive these AML cell lines into terminal growth arrest. G1/0 arrest is also suggested in patient-derived AML by TH 1 cytokines or supernatants from Zoledronate-stimulated or aCD3/aCD28-stimulated PBMCs. Thus, we show for the first time that senescence is induced in AML cells by combined IFN-γ and TNF-α, and that these cytokines can be derived either from TCR-engineered CD4 + T cells, or intriguingly from Virus-specific as well as innate Vδ2 + T cells responding to their cognate antigens, namely T-cell responses targeting an antigen that is NOT expressed by the leukemic cells. Graphical Abstract: ga1 Highlights: TH 1 cytokines IFN-γ and TNF-α combined induce senescence in acute myeloid leukemia. IFN-γ/TNF-α from any TH 1 cell responding to its cognate antigen can induce senescence. Sensitivity for senescence induction by TNF-α/IFN-γ occurs in physiologic concentrations ranging over more than 2 log phases. … (more)
- Is Part Of:
- Leukemia research. Volume 117(2022)
- Journal:
- Leukemia research
- Issue:
- Volume 117(2022)
- Issue Display:
- Volume 117, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 117
- Issue:
- 2022
- Issue Sort Value:
- 2022-0117-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-06
- Subjects:
- AML -- Senescence induction -- TH1 cytokines -- Combined IFN-γ+ and TNF-α+ -- PRAME -- CD4+ T cells -- Virus-specific T cells -- γδT cells
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.leukres.2022.106842 ↗
- Languages:
- English
- ISSNs:
- 0145-2126
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21516.xml